The Simultaneous Use of Supraclavicular and Distal Blocks
NCT ID: NCT01989312
Last Updated: 2013-11-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
75 participants
INTERVENTIONAL
2012-02-29
2013-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Sixty two patients undergoing upper extremity surgery will be randomized to supraclavicular only (Group S, n=31) or supraclavicular + distal (Group SD, n=31) group. Patients in group S will receive 32 mL of lidocaine 1.5% + epinephrine 5µg/mL and in group SD receive 20 mL of lidocaine 1.5% + epinephrine 5µg/mL followed by a distal median, radial, and ulnar nerve blocks using 50:50 mixture of lidocaine 2% + levobupivacaine 0.5% (4 mL/nerve). Sensory and motor block of the ulnar, median, radial and musculocutaneous nerves will be assessed every 5 minutes starting at the 10th minutes. The imaging, needling and performance times will be recorded. Also the onset and anesthesia related times, need for analgesic and first analgesic time will be noted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
supraclavicular block
A supraclavicular block with 32 mL of lidocaine 1.5% + epinephrine 5µg/mL was performed for the anaesthetic management of the forearm and hand.
intravenous cannulation.
A 18-or 20-gauge intravenous (iv) catheter was placed to the contralateral arm according to the surgical site
Intravenous cannulation.
A 18-or 20-gauge intravenous (iv) catheter was placed to the contralateral arm according to the surgical site
Routine ASA monitoring
Monitorization with ECG, noninvasive blood pressure and spO2.
Premedication midazolam
Premedication with 0.03 mg/kg midazolam iv
Lidocaine
Epinephrine
Supraclavicular and median, ulnar, radial blocks
Patients in this group received 20 mL of lidocaine 1.5% + epinephrine 5µg/mL for supraclavicular block and after the supraclavicular block they recieved a distal median, radial, and ulnar nerve blocks using 50:50 mixture of lidocaine 2% + levobupivacaine 0.5% (4 mL/nerve).
Supraclavicular block and ultrasound-guided ulnar, median and radial nerve blocks.
Supraclavicular block with 20 mL of lidocaine 1.5% + epinephrine 5µg/mL and the addition of ultrasound-guided ulnar, median and radial nerve blocks. For that 12 mL of local anesthetic solution of a 50:50 mixture of lidocaine 2% and levobupivacaine 0.5% (4 mL/nerve) was used.
Intravenous cannulation.
A 18-or 20-gauge intravenous (iv) catheter was placed to the contralateral arm according to the surgical site
Routine ASA monitoring
Monitorization with ECG, noninvasive blood pressure and spO2.
Premedication midazolam
Premedication with 0.03 mg/kg midazolam iv
Lidocaine
Epinephrine
Levobupivacaine
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
intravenous cannulation.
A 18-or 20-gauge intravenous (iv) catheter was placed to the contralateral arm according to the surgical site
Supraclavicular block and ultrasound-guided ulnar, median and radial nerve blocks.
Supraclavicular block with 20 mL of lidocaine 1.5% + epinephrine 5µg/mL and the addition of ultrasound-guided ulnar, median and radial nerve blocks. For that 12 mL of local anesthetic solution of a 50:50 mixture of lidocaine 2% and levobupivacaine 0.5% (4 mL/nerve) was used.
Intravenous cannulation.
A 18-or 20-gauge intravenous (iv) catheter was placed to the contralateral arm according to the surgical site
Routine ASA monitoring
Monitorization with ECG, noninvasive blood pressure and spO2.
Premedication midazolam
Premedication with 0.03 mg/kg midazolam iv
Lidocaine
Epinephrine
Levobupivacaine
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* American Society of Anesthesiologists (ASA) physical status I-III
* Scheduled for elective hand and forearm surgery
Exclusion Criteria
* preexisting neuropathy
* coagulopathy
* allergy to agents used
* pregnancy
* body mass index \> 35 kg/m2
* chronic obstructive pulmonary disease
* infection or previous surgery in the supraclavicular area
* systemic infection
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ankara University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Basak Ceyda MECO
MD,DESA
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Basak Ceyda Meco, MD, DESA
Role: PRINCIPAL_INVESTIGATOR
Ankara University Faculty of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ankara University Faculty of Medicine, Ibni Sina Hospital colonoscopy lab
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
03-99-12
Identifier Type: -
Identifier Source: org_study_id